Hosokawa Micron, AnGes MG Succeed in Creating Composite Nanoparticle Contating NF-Kappa B Decoy Oligodeoxynucleotide.
NFkB decoy oligo is a nucleic acid agent developed by AnGes MG. Using Hosokawa's proprietary PLGA (lactide-co-gycolide) nanoparticles, it can improve the efficiency of drug delivery.
In addition, Hosokawa Micron has begun assessing the pharmacological effect of NFkB decoy oligo-containing nanoparticle on skin diseases including atopic dermatitis and psoriasis.
The two companies expect that this achievement will contribute to further development in protein, genetic and nucleic acid drugs.
Source: JCN http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Oct 6, 2005|
|Previous Article:||FANCL Announces Research Results of Antiaging Material Silybin at IFSCC International Conference 2005.|
|Next Article:||PhramaDesign, Pharma Valley Center to Collaborate in Developing Transcriptional Regulator-targeted Anti-tumor Agents.|